A pilot intervention

Article

The background to the Egyptian Menia study

We wanted to look at the factors at work behind the gender gap in relation to the uptake of eye care services and how these could be corrected. The partners involved in the research included CIDA, KCCO, the local NGO, MOH.

"Our aims were to sensitise community members about the gender gap, enabling them to identify and deal with related factors and people eligible for eye care. In turn, we wanted to assess the impact of this increased awareness on bridging the gender gap in eye health.

So what did we do?

The two villages were divided into sectors to which health workers were assigned. Following the training they were able to conduct house-to-house interaction with family members and encourage them, particularly women, to use the eye care services available in the community.

What was achieved?

Thirty five community members were trained as advocators for gender and eye health. Three local NGOs now include gender and eye care on their agendas. The increase in uptake of TT surgery by women was 10% at the central hospital and 40% at the camp site. For cataract surgery it was 5% and 30% respectively.

Overall, the work of the Al Noor-Magrabi Foundation has done a great deal towards combating needless blindness and supporting eye care services, particularly in relation to gender. Government has been encouraged to relocate ophthalmologists to more rural areas and another key to their success has clearly been the lesson that people need to be supported in seeking services. This includes issues like transport and additional capacity to cope with increased demand for services. This builds trust between communities and those providing the eye care.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.